Literature DB >> 2720589

Olfactory neuroblastoma.

T A O'Connor1, P McLean, G J Juillard, R G Parker.   

Abstract

Fifteen patients with olfactory neuroblastoma were treated during the 17-year period of 1969 to 1986. Data was analyzed with respect to age at presentation, sex, presenting signs and symptoms, stage, and results of treatment. Age ranged from 4 to 67 years with the median age being 27 years. Median follow-up was 8 years. Local control was achieved in nine of nine patients or 100% with successful surgical resection, i.e., minimal residual disease, followed by postoperative radiation therapy (45 to 65 Gy) was employed. There were no distant failures when the primary site was controlled. Regional lymph node metastases were infrequent: only 13% (two of 15 patients) presented with positive nodes. Three of four patients treated initially with surgery alone had a local recurrence, two of which were successfully salvaged by combined therapy. There were four patients treated with radiation therapy alone: three had persistent disease after radiation therapy, and one patient was controlled with 65 Gy. Olfactory neuroblastoma has a propensity to recur locally when treated with surgery alone. The authors' experience suggests excellent local control can be achieved with surgery immediately followed by radiation therapy. Thus the authors recommend planned combined treatment for all resectable lesions.

Entities:  

Mesh:

Year:  1989        PMID: 2720589     DOI: 10.1002/1097-0142(19890615)63:12<2426::aid-cncr2820631209>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Esthesioneuroblastoma in Maffucci's syndrome.

Authors:  Sobha Kurian; Esmer Ertan; Barbara Ducatman; Edward B Crowell; Christopher Rassekh
Journal:  Skeletal Radiol       Date:  2004-06-19       Impact factor: 2.199

2.  Olfactory neuroblastomas: survival rate and prognostic factor.

Authors:  Sung-Kyun Hwang; Sun-Ha Paek; Dong Gyu Kim; Yoon-Kyung Jeon; Je G Chi; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

3.  Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.

Authors:  P P Kumar; F P Ogren; R D McComb; E O Jones; G F McCaul
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

4.  Esthesioneuroblastomas: Reservations and Recommendations.

Authors:  Rajesh Nair; Bhavna Nayal; Vinod Kumar; Padmapriya Jaiprakash
Journal:  J Clin Diagn Res       Date:  2016-07-01

5.  Esthesioneuroblastoma (olfactory neuroblastoma) with hemorrhage: an unusual presentation.

Authors:  Prakash Sampath; Michael C Park; Dara Huang; Curtiland Deville; Selina Cortez; Prakash Chougule
Journal:  Skull Base       Date:  2006-08

6.  Esthesioneuroblastoma in a young child.

Authors:  B Gül; S Kulaçoğlu; M Yüksel; H Doğan; A I Okten
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

7.  Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Authors:  M E Carney; R C O'Reilly; B Sholevar; O I Buiakova; L D Lowry; W M Keane; F L Margolis; J L Rothstein
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

Review 8.  Radiotherapy alone for local tumour control in esthesioneuroblastoma.

Authors:  G Benfari; M Fusconi; A Ciofalo; A Gallo; G Altissimi; T Celani; M De Vincentiis
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-12       Impact factor: 2.124

9.  Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience.

Authors:  P Daniel Ward; Jason A Heth; B Gregory Thompson; Lawrence J Marentette
Journal:  Skull Base       Date:  2009-03

10.  Preservation of olfaction after unilateral endoscopic approach for resection of esthesioneuroblastoma.

Authors:  Aaron Wessell; Ameet Singh; Zachary Litvack
Journal:  J Neurol Surg Rep       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.